Department of Neurosurgery and Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, China.
Department of Neurosurgery, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou, China.
Neurochem Res. 2024 Apr;49(4):998-1007. doi: 10.1007/s11064-023-04095-4. Epub 2024 Jan 3.
This work aimed to study the role and mechanism of SIRT5 regulation of ferroptosis in cerebral ischemia-reperfusion (I/R) injury. A model of middle cerebral artery occlusion in rats was prepared using the method of thread occlusion. The ferroptosis inhibitor was injected intraperitoneally while the SIRT5 interfering lentivirus were injected into the brain, and neurological disorders were scored in the rats. TTC staining was used to detect infarct volume, and immunohistochemistry was used to detect the expression of SIRT5 in tissues. Rat hippocampal neuronal cells H19-7 were transduced with SIRT5 interfering lentivirus and ferroptosis was induced using erastin. The CCK8 detection kit was used to detect cell viability. Commercial kits were used to detect levels of iron ions, ROS, MDA, SOD, and inflammatory factor (TNF-α and IL-6) in brain tissue or cell supernatant. Western blot was used to detect the expression changes of ferroptosis related proteins GPX4, Nrf2, and HO-1 in tissues or cells. Compared with the sham group, the MCAO model group showed higher levels of neurological impairment score, increased cerebral infarction volume, iron ions, inflammatory factors, and oxidative stress levels in rats. Compared with the MCAO group, the MCAO + fer-1 group exhibited lower levels of neurological impairment scores, cerebral infarction volume, decreased iron ions, inflammatory factors, and oxidative stress levels in rats. Meanwhile, compared with the MCAO + DMSO/LV-shRNA group, the MCAO + fer-1/LV-shSIRT5 group showed a significant decrease in neurological impairment scores, cerebral infarction volume, iron ions, inflammatory factors, and oxidative stress levels in rats. In vitro experiments have found that LV-shSIRT5 can prevent erastin-induced cell ferroptosis. In summary, SIRT5 regulates ferroptosis through the Nrf2/HO-1 signaling axis to participate in ischemia-reperfusion injury in ischemic stroke.
本研究旨在探讨 SIRT5 调控脑缺血再灌注(I/R)损伤中铁死亡的作用和机制。采用线栓法制备大鼠大脑中动脉闭塞模型,腹腔内注射铁死亡抑制剂,脑内注射 SIRT5 干扰慢病毒,对大鼠进行神经功能障碍评分。TTC 染色检测脑梗死体积,免疫组化检测组织中 SIRT5 的表达。将 SIRT5 干扰慢病毒转染大鼠海马神经元细胞 H19-7,用 erastin 诱导铁死亡。CCK8 检测试剂盒检测细胞活力。采用商业试剂盒检测脑组织或细胞上清液中铁离子、ROS、MDA、SOD 和炎症因子(TNF-α 和 IL-6)水平。Western blot 检测组织或细胞中与铁死亡相关的蛋白 GPX4、Nrf2 和 HO-1 的表达变化。与假手术组相比,MCAO 模型组大鼠神经功能损伤评分升高,脑梗死体积增大,铁离子、炎症因子和氧化应激水平升高。与 MCAO 组相比,MCAO+fer-1 组大鼠神经功能损伤评分降低,脑梗死体积减小,铁离子、炎症因子和氧化应激水平降低。与 MCAO+DMSO/LV-shRNA 组相比,MCAO+fer-1/LV-shSIRT5 组大鼠神经功能损伤评分降低,脑梗死体积减小,铁离子、炎症因子和氧化应激水平降低。体外实验发现,LV-shSIRT5 可预防 erastin 诱导的细胞铁死亡。综上所述,SIRT5 通过 Nrf2/HO-1 信号轴调节铁死亡参与缺血性脑卒中的缺血再灌注损伤。